The Roivant Sciences subsidiary Priovant Therapeutics has announced positive results from the Phase II BEACON study of brepocitinib in cutaneous sarcoidosis (CS).
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ 21.6 ...
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (Δ21.6 ...
Aspiring computer science student Alex Seungyong Yang sees AI as both a challenge and opportunity as he enters university as ...
Coimbatore (Tamil Nadu) [India], February 11: CS Academy, Coimbatore, in partnership with the Tamil Nadu Electricity Board (TNEB), has recently launched The Energy Conservation Project, a two-month, ...
The Beacon trial enrolled 31 patients, randomizing them at a rate of 3:2:2 to receive a daily 45-mg oral dose of brepocitinib ...
With the exception of UC San Diego, the University of California system is seeing a downward trend in undergraduate computer science majors amid looming questions about AI and traditional career paths ...
Malinin has already secured a gold medal at the 2026 Winter Olympics, as he was part of the Team USA squad that captured gold ...
Ilia Malinin’s “Quad God” nickname draws attention as he aims for more gold medals at the 2026 Winter Olympics.
VANCOUVER, BC / ACCESS Newswire / February 5, 2026 /Gold Terra Resource Corp. (TSXV:YGT)(Frankfurt:TX0)(OTCQB:YGTFF) ("Gold Terra" or the "Company") is pleased to announce the completion of eight (8) ...
Tuko News on MSN
Boda boda rider earning KSh 120k in Dubai thanks CS Alfred Mutua for life-changing chance
A Kenyan boda boda rider in Dubai has thanked Labour CS Alfred Mutua for offering him the job opportunity, sharing his joy at ...
Brepocitinib 45 mg significantly improved cutaneous sarcoidosis disease activity, achieving a 22.3-point improvement in mean CSAMI-A at Week 16 versus a 0.7-point improvement in placebo (?21.6 PPriova ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results